CIA
VSTM icon

Capital Impact Advisors’s Verastem VSTM Stock Holding History

Capital Impact Advisors’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,384
Closed -$152K – 303
2014
Q4 		$152K Buy
1,384
+1,383
+138,300% +$150K 0.07% 165
2014
Q3 		$141 Sell
1
-1,383
-100% -$145K ﹤0.01% 158
2014
Q2 		$150K Buy
+1,384
New +$151K 0.11% 199

Other funds holding VSTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Capital Impact Advisors's VSTM Position: Q1 2015 in Review

Capital Impact Advisors sold out of Verastem (VSTM) in Q1 2015, closing a stake of 1,384 shares — an estimated $152K sold.

Capital Impact Advisors first reported a position in VSTM in Q2 2014 and held it in 3 quarters. The position peaked at $152K in Q4 2014. 86 funds tracked by Wall St. Rank hold VSTM as of Q1 2015.

  • Capital Impact Advisors reported no remaining Verastem position as of Q1 2015 after selling out during the quarter.
  • Capital Impact Advisors sold 1,384 Verastem shares in Q1 2015, an estimated $152K.
  • Capital Impact Advisors first reported a position in Verastem in Q2 2014 and held it in 3 quarters.
  • Capital Impact Advisors's Verastem position peaked at $152K in Q4 2014.
  • 86 funds tracked by Wall St. Rank held Verastem as of Q1 2015.

Based on Capital Impact Advisors's 13F filing for Q1 2015, filed 29 May 2015.